14 results on '"Kushnir, Vitaly A."'
Search Results
2. New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens.
- Author
-
Gleicher N, Kushnir VA, Darmon SK, Wang Q, Zhang L, Albertini DF, and Barad DH
- Subjects
- Adrenal Glands embryology, Adrenal Insufficiency complications, Adrenal Insufficiency diagnosis, Adult, Autoimmunity immunology, Female, Fertilization in Vitro, Humans, Middle Aged, Ovary metabolism, Phenotype, Polycystic Ovary Syndrome complications, Polycystic Ovary Syndrome diagnosis, Prognosis, Retrospective Studies, Testosterone metabolism, Thyroid Gland metabolism, Treatment Outcome, Zona Reticularis metabolism, Adrenal Glands pathology, Androgens metabolism, Anti-Mullerian Hormone metabolism, Infertility, Female metabolism, Polycystic Ovary Syndrome metabolism
- Abstract
How anti-Müllerian hormone (AMH) and testosterone (T) interrelate in infertile women is currently largely unknown. We, therefore, in a retrospective cohort study investigated how infertile women with high-AMH (AMH ≥75th quantile; n=144) and with normal-AMH (25th-75th quantile; n=313), stratified for low-T (total testosterone ≤19.0ng/dL), normal-T (19.0-29.0ng/dL) and high-T (>29.0ng/dL) phenotypically behaved. Patient age, follicle stimulating hormone (FSH), dehyroepiandrosterone (DHEA), DHEA sulphate (DHEAS), cortisol (C), adrenocorticotrophic hormone (ACTH), IVF outcomes, as well as inflammatory and immune panels were then compared between groups, with AMH and T as variables. We identified a previously unknown infertile PCOS-like phenotype, characterized by high-AMH but, atypically, low-T, with predisposition toward autoimmunity. It presents with incompatible high-AMH and low-T (<19.0ng/dL), is restricted to lean PCOS-like patients, presenting delayed for tertiary fertility services. Since also characterized by low DHEAS, low-T is likely of adrenal origina, and consequence of autoimmune adrenal insufficiency since also accompanied by low-C and evidence of autoimmunity. DHEA supplementation in such patients equalizes low- to normal-T and normalizes IVF cycle outcomes. Once recognized, this high-AMH/low-T phenotype is surprisingly common in tertiary fertility centers but, currently, goes unrecognized. Its likely adrenal autoimmune etiology offers interesting new directions for investigations of adrenals control over ovarian function via adrenal androgen production., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
3. Associations between peripheral androgens and cortisol in infertile women.
- Author
-
Gleicher N, Seier K, Kushnir VA, Weghofer A, Wu YG, Wang Q, Albertini DF, and Barad DH
- Subjects
- Adult, Anti-Mullerian Hormone blood, Female, Humans, Sex Hormone-Binding Globulin analysis, Testosterone Congeners blood, Thyrotropin blood, Androgens blood, Hydrocortisone blood, Infertility, Female blood
- Abstract
Testosterone has in recent years been proven essential for normal growth and maturation of small growing follicles. Concomitantly, low functional ovarian reserve (LFOR), characterized by a small growing follicle pool, has been associated with low testosterone levels, which can be of ovarian and/or adrenal origin. In this study we, therefore, investigated whether peripheral sex steroid precursors and testosterone levels potentially reflect on adrenal function. In a retrospective cohort study of 355 consecutive infertile women, who presented to an academically affiliated fertility center in New York City, we investigated in a series of statistical models whether low peripheral sex steroid precursors and testosterone are associated with peripheral cortisol (C) levels, reflecting adrenal function. To determine potential correlations, we investigated the dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), androstenedione (AD), total testosterone (TT), free testosterone (FT); sex hormone binding globulin (SHBG), anti-Müllerian hormone (AMH), thyroid stimulating hormone (TSH) and C in a series of multivariate and logistic regression analyses, utilizing C either as a continuous variable or with cut off <5.0μg/dL, and TT only as a continuous variable. Practically all models demonstrated significant predictability of peripheral sex hormone precursors for C levels, with DHEA demonstrating the strongest and most consistent predictability as an individual parameter and as part of the DHEAS/DHEA ratio. We conclude that in infertile women peripheral sex hormone precursors, especially DHEA, reflect C levels and, therefore, adrenal function. In infertile women, at all ages low levels of sex hormone precursors, therefore, should be considered indications for further adrenal assessments., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
4. More on the conversion of DHEA to testosterone.
- Author
-
Shohat-Tal A, Sen A, Barad DH, Kushnir VA, and Gleicher N
- Subjects
- Animals, Female, Humans, Androgens deficiency, Dehydroepiandrosterone metabolism, Infertility, Female genetics, Testosterone metabolism
- Published
- 2015
- Full Text
- View/download PDF
5. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
- Author
-
Kushnir VA, Halevy N, Barad DH, Albertini DF, and Gleicher N
- Subjects
- Adult, Aging blood, Aging pathology, Female, Fertility physiology, Humans, Obesity blood, Obesity pathology, Polycystic Ovary Syndrome pathology, Androgens blood, Anti-Mullerian Hormone blood, Ovarian Reserve, Polycystic Ovary Syndrome blood
- Abstract
Background: To assess the changes in phenotypes and endocrine profiles of women with polycystic ovary syndrome (PCOS) with advancing age., Methods: In a cross-sectional study conducted at a private tertiary fertility clinical and research center we identified anonymized electronic records of 37 women who had presented with a prior diagnosis of PCOS. They were stratified as younger (<35 years) and older (≥40 years). As controls, we identified 43 women with age-specific low functional ovarian reserve and 14 young women with normal functional ovarian reserve. Endocrine profiles for each group were evaluated based on total (TT) and free testosterone (FT), anti-Müllerian hormone (AMH) and sex hormone binding globulin (SHBG)., Results: Patients including those with PCOS were mostly non-obese, evidenced by normal BMIs (21.6 ± 6.0) with no differences between study groups. Young PCOS patients presented with a typical pattern of significant hyperandrogenemia and elevated AMH in comparison to young women with normal functional ovarian reserve [TT 44.0 (32.9-58.7) vs. 23.9 (20.3-28.1) ng/dL, (P<0.05); and AMH 7.7 (6.2-9.1) vs. 2.5 (2.0-3.0) ng/mL, (P<0.05)]. With advancing age, hyperandrogenemia in PCOS diminished in comparison to young women with normal functional ovarian reserve, resulting in similar TT levels [28.6 (19.7-37.5) vs. 23.9 (20.3-28.1) ng/dL]. Though also declining, AMH remained significantly elevated in older PCOS women in comparison to young women with normal functional ovarian reserve [4.0 (2.7-5.2) vs. 2.5 (2.0-3.0) ng/mL, (P<0.05)]. Patients with low functional ovarian reserve demonstrated significantly lower AMH at both young and older ages compared to women with normal functional ovarian reserve (P<0.05 for both). However, among patients with low functional ovarian reserve no differences were observed at young compared to older ages in TT [17.6 (12.9-24.1) vs. 18.1 (13.6-24.1) ng/dL)] and AMH [0.4 (0.3-0.6) vs. 0.3 (0.2-0.5) ng/mL]. SHBG did not differ significantly between groups but trended opposite to testosterone., Conclusions: The PCOS population predominantly consisted of non-obese phenotype at both young and advanced ages. This suggests that patients with "classical" obese PCOS phenotype rarely reach tertiary infertility care, while non-obese PCOS patients may be more resistant to lower levels of infertility treatments. PCOS patients also demonstrate more precipitous declines in testosterone then AMH with advancing age. These data support incorporation of AMH as diagnostic criterion for PCOS regardless of age, and imply that testosterone should not be relied upon in the diagnosis of PCOS in older women.
- Published
- 2015
- Full Text
- View/download PDF
6. Poor responders and androgen adjuvant treatment: "Still haven't found what I'm looking for …".
- Author
-
Gleicher N, Barad DH, Kushnir VA, Sen A, and Weghofer A
- Subjects
- Female, Humans, Pregnancy, Androgens metabolism, Blastocyst drug effects, Dehydroepiandrosterone blood, Dehydroepiandrosterone pharmacology, Oocytes drug effects, Ovary drug effects, Ovulation Induction, Testosterone blood
- Published
- 2014
- Full Text
- View/download PDF
7. Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.
- Author
-
Barad DH, Kushnir VA, Lee HJ, Lazzaroni E, and Gleicher N
- Subjects
- Adult, Case-Control Studies, Cohort Studies, Drug Synergism, Female, Fertilization in Vitro, Follicle Stimulating Hormone blood, Humans, Infertility, Female blood, Infertility, Female etiology, Infertility, Female pathology, Infertility, Male, Male, Oocyte Retrieval, Ovarian Follicle cytology, Ovarian Follicle drug effects, Ovarian Follicle pathology, Ovarian Reserve, Primary Ovarian Insufficiency physiopathology, Retrospective Studies, Severity of Illness Index, Androgens pharmacology, Dehydroepiandrosterone pharmacology, Fertility Agents, Female pharmacology, Follicle Stimulating Hormone pharmacology, Infertility, Female therapy, Oogenesis drug effects, Ovulation Induction
- Abstract
Background: In various animal models androgens have been demonstrated to enhance follicle stimulating hormone (FSH) activity on granulosa cells during small growing follicle stages. To assess whether similar synergism may also exist in humans we investigated women on androgen (dehydroepiandrosterone, DHEA) supplementation with varying concomitant FSH exposure., Methods: In a case controlled cohort study we determine if time interval between IVF cycles of IVF treatment with FSH had an effect on ovarian response to ovulation induction in women supplemented with DHEA. Among 85 women with known low functional ovarian reserve (LFOR), supplemented with DHEA, and undergoing at least 3 consecutive IVF cycles, 68 demonstrated short (<120 days) intervals between repeated cycles (Group 1) and were, therefore, considered to have consistent FSH exposure. In contrast 17 women (Group 2) demonstrated long (>=120 days) intervals between repeated cycles and, therefore, were considered to demonstrate inconsistent FSH exposure. Trends in oocyte yields were compared between these groups, utilizing mixed model repeated measures ANOVA, adjusted for initial age and FSH dose., Results: Only women in Group I demonstrated a linear increase in oocyte yields across their three cycles of treatments (F=7.92; df 1, 68.6; p=0.017). Moreover, the analysis revealed a significant interaction between the two patient groups and cycle number for retrieved oocytes (F=6.32, df=2, 85.9, p=0.003)., Conclusions: This study offers preliminary confirmatory evidence that repeated short interval exposure to androgens in combination with FSH improves human FOR. A higher level of evidence will require prospectively randomized studies.
- Published
- 2014
- Full Text
- View/download PDF
8. Hypoandrogenism in association with diminished functional ovarian reserve.
- Author
-
Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, and Barad DH
- Subjects
- Adult, Age Factors, Cohort Studies, Dehydroepiandrosterone blood, Dehydroepiandrosterone Sulfate blood, Female, Follicle Stimulating Hormone blood, Humans, Hydrocortisone blood, Testosterone blood, Androgens blood, Anti-Mullerian Hormone blood, Ovary physiology
- Abstract
Study Question: Is diminished functional ovarian reserve (DFOR) associated with low androgen levels?, Summary Answer: Low androgen levels are associated with DFOR at all ages., What Is Known Already: Androgen supplementation via dehydroepiandrosterone (DHEA) has been reported to improve functional ovarian reserve (FOR); pregnancy rates in IVF cycles are associated with how well DHEA converts to testosterone (T); and androgen effects through the androgen receptor have been demonstrated in mice to beneficially affect early stages of follicle maturation., Study Design, Size, Duration: In a controlled cohort study we investigated consecutive women presenting to our center with two forms of DFOR, premature ovarian aging/occult primary ovarian insufficiency (POA/OPOI) and physiologic diminished ovarian reserve (DOR). As controls for POA/OPOI patients, infertile women with normal age-specific FOR were recruited., Participants/materials, Settings, Methods: The study involved 140 women with POA/OPOI, defined as age <38 years and abnormally low FOR by age-specific FSH and/or anti-Müllerian hormone (AMH), 166 women with DOR, defined as women age >40 years. Forty-nine control patients <38 years demonstrated normal FOR by FSH and/or AMH. In all three patient groups dehydroepiandrosterone (DHEA), DHEA-sulfate (DHEAS), total testosterone (TT) and free testosterone (FT) at the time of initial presentation to our fertility center were assessed. In a small subgroup of women early morning cortisol levels were also assessed., Main Results and the Role of Chance: DHEAS marginally varied between the three groups (P = 0.04), with older women with DOR actually demonstrating higher levels than controls (P = 0.03). TT differed between the three groups more profoundly (P = 0.005), with women with POA/OPOI demonstrating significantly lower levels than controls (P = 0.009). Adjustment for body mass index, age and race in principle maintained observed differences in TT between groups, while adjustment for FMR1 (fragile X mental retardation 1) genotypes/sub-genotypes eliminated all differences. All three patient groups demonstrated low morning cortisol levels., Limitations, Reasons for Caution: While results support lower androgen levels in women with DOR, and even more so in women with POA/OPOI, presented data should be viewed as preliminary, considering the known variability of androgen levels and the small number of women in whom morning cortisol levels were available., Wider Implications of the Findings: Especially at young ages DFOR appears associated with significant hypoandrogenism (low T) in comparison with young control patients with normal FOR, raising the question whether this hypoandrogenism originates in adrenals or ovaries. POA/OPOI, thus, phenotypically mimics the polycystic ovary syndrome, where similar questions arise, though in regard to hyperandrogenism., Study Funding/competing Interest(s): This research was supported by the Foundation for Reproductive Medicine, a not-for-profit medical research foundation and intramural funds from the Center for Human Reproduction. N.G. and D.H.B are members of the Board of the Foundation for Reproductive Medicine. N.G., A.W. and D.H.B. received research support, lecture fees and travel support from a variety of pharmaceutical and medical device companies, none in any way related to the issues discussed in this manuscript. N.G. and D.H.B. are listed as co-inventors on two, already granted US user patents, which claim therapeutic benefits from DHEA supplementation in women with DFOR and DOR: both authors are also listed on additional pending patents in regard to DHEA supplementation and on pending patents, claiming diagnostic and therapeutic benefits from the determination of CGG repeats on the FMR1 gene. N.G. is the owner of the Center for Human Reproduction, where this research was performed.
- Published
- 2013
- Full Text
- View/download PDF
9. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women
- Author
-
Kushnir, Vitaly A., Darmon, Sarah K., Barad, David H., Weghofer, Andrea, and Gleicher, Norbert
- Published
- 2019
- Full Text
- View/download PDF
10. Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age
- Author
-
Gleicher, Norbert, Kushnir, Vitaly A., Darmon, Sarah K., Wang, Qi, Zhang, Lin, Albertini, David F., and Barad, David H.
- Published
- 2018
- Full Text
- View/download PDF
11. Is there an androgen level threshold for aneuploidy risk in infertile women?
- Author
-
Gleicher, Norbert, McCulloh, David H., Kushnir, Vitaly A., Ganguly, Nandita, Barad, David H., Goldman, Kara N., Kushnir, Mark M., Albertini, David F., and Grifo, James A.
- Subjects
ANDROGENS ,ANDROSTANE ,ANEUPLOIDY ,PLOIDY ,INFERTILITY - Abstract
Background: Low functional ovarian reserve (LFOR) has been associated with hypoandrogenemia and increased embryo aneuploidy, while androgen supplementation has been reported to improve aneuploidy rates. We, therefore, assessed whether in infertile women undergoing in vitro fertilization (IVF) androgen concentrations are associated with aneuploidy rates. Methods: This study was performed in 2 academically affiliated fertility centers in New York City and an academically affiliated steroid chemistry laboratory in Utah. Androgen concentrations were measured in blinded fashion from 84 infertile women (age 40.3 +/- 2.4 years) at New York University (NYU), using a validated LC-MS/MS method, in cryopreserved serum samples of patients who had undergone IVF with concomitant preimplantation genetic screening (PGS), utilizing a 24-chromosome platform. The Center for Human Reproduction (CHR) provided plasma samples of 100 historical controls (ages 38.6+/-5.0 years) undergoing IVF without PGS. Statistical comparisons were made of androgen concentrations, and of associations between androgen concentrations and embryo aneuploidy. Results: Women undergoing IVF + PGS at NYU revealed no association between embryo aneuploidy and androgen concentrations but demonstrated significantly lower androgen concentrations than the 100 control patients from CHR, Conclusions: Though this study revealed no association between androgen levels and embryo ploidy, the extremely low androgen levels in the NYU study group raise the possibility of a threshold effect below which testosterone no longer affects aneuploidy. Before an androgen effect on embryo ploidy can be completely ruled out, a patient population with more normal androgen levels has to be investigated. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
12. Some aspects of interactivity between endocrine and immune systems required for successful reproduction.
- Author
-
Weghofer, Andrea, Himaya, Eric, Kushnir, Vitaly A., Barad, David H., Lazzaroni-Tealdi, Emanuela, Yao Yu, Yan-Guang Wu, and Gleicher, Norbert
- Subjects
HUMAN reproduction ,ENDOCRINE system ,IMMUNE system ,ANDROGENS ,PSYCHOLOGY ,FEMALE infertility ,TESTOSTERONE ,HUMAN embryo research - Abstract
Background: In successful reproduction, endocrine and immune systems closely interact. We here attempt to further elucidate the relationship between androgen levels, systemic activation of the immune system and reproductive success in infertile women, utilizing 2 distinct infertile patient cohorts. Methods: In Group 1, we investigated 322 women (ages 38.6 +/- 5.4 years) at initial presentation; in Group 2 125 women undergoing in vitro fertilization (169 IVF cycles, ages 38.9 +/- 5.5 years). In Group 1, we assessed androgens and an immune panel, previously demonstrated to discriminate between activated quiescent immune systems; in Group 2, utilizing the same immune panel, we investigated whether immune system activation relates to embryo quality in IVF cycles. Results: No individual immune test within the immune panel was associated with androgen levels. The total/free testosterone ratio (TT/FT) was, however, significantly associated with presence of gammopathies (in IgG, IgM, IgA, IgE; P = 0.026). Surprisingly, immune system activation was associated with significantly improved embryo quality (P = 0.008), a finding persistent after adjustment for age and repeat IVF cycles (P = 0.006). Conclusions: Association of immune system activation with improved embryo quality concurs with previously reported immune activation in association with normal functional ovarian reserve (FOR) and normal androgen levels, while, counter intuitively, hypoandrogenism and low FOR are associated with lack of immune system activation. Mild immune system activation, therefore, likely appears essential for establishment of pregnancy, and may be regulated by androgens. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women?
- Author
-
Gleicher, Norbert, Weghofer, Andrea, Kushnir, Vitaly A., Shohat-Tal, Aya, Lazzaroni, Emanuela, Ho-Joon Lee, and Barad, David H.
- Subjects
TESTOSTERONE ,IMMUNE system ,FEMALE infertility ,AUTOIMMUNITY ,FERTILIZATION in vitro - Abstract
Background: Low functional ovarian reserve (FOR) is at all ages associated with low testosterone (T) levels. Causes are, however, unknown. We, therefore, investigate whether androgens with low FOR are associated with non-specific immune system activation. Methods: 322 infertile women with low and normal FOR (controls) were assessed with a broadly based immune profile, which in previous studies has proven effective in differentiating infertile patients with and without immune system activation. Patients were either immune-positive (greater than or equal to one positive tested parameter) or immune negative (no positive test). 135 suffered from prematurely diminished FOR (POA/OPOI; < age 38), 155 from physiologic diminished FOR due to age (DOR; > age 40), and 32 were controls (< age 38 with normal age-specific FOR). Prevalence of immune-positive vs. negative was assessed in all 3 patient groups. Results: Women with immune abnormalities, overall, demonstrated higher total T (TT, P = 0.004) and free T (FT, P < 0.001) levels than those without. The three clinical and two immunologic-defined patient groups demonstrated significant statistical interaction in mean TT (P = 0.008), with mean TT and FT in women with positive immune findings being significantly higher in control than in POA/OPOI and physiologic DOR patients (all 4 differences P < 0.001). No such differences between the three groups were seen in women without immune abnormalities. Conclusions: In this study we used a definition of immune-positivity, which favors sensitivity over specificity, resulting in significant numbers of false-positives but likely only few false-negatives. The study allows suggesting the possibility of an immune system-derived androgen-production factor (APF), which maintains normal androgen levels but is deficient in women with low FOR and immune system inactivity. Existence of such an APF would suggest the presence of a still unknown functional adrenal autoimmune system. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
14. Genetics of androgen metabolism in women with infertility and hypoandrogenism.
- Author
-
Shohat-Tal, Aya, Sen, Aritro, Barad, David H., Kushnir, Vitaly, and Gleicher, Norbert
- Subjects
- *
GENETICS , *ANDROGENS , *DEHYDROEPIANDROSTERONE , *ADRENOCORTICAL hormones , *STEROIDOGENIC acute regulatory protein - Abstract
Hypoandrogenism in women with low functional ovarian reserve (LFOR, defined as an abnormally low number of small growing follicles) adversely affects fertility. The androgen precursor dehydroepiandrosterone (DHEA) is increasingly used to supplement treatment protocols in women with LFOR undergoing in vitrofertilization. Due to differences in androgen metabolism, however, responses to DHEA supplementation vary between patients. In addition to overall declines in steroidogenic capacity with advancing age, genetic factors, which result in altered expression or enzymatic function of key steroidogenic proteins or their upstream regulators, might further exacerbate variations in the conversion of DHEA to testosterone. In this Review, we discuss in vitro studies and animal models of polymorphisms and gene mutations that affect the conversion of DHEA to testosterone and attempt to elucidate how these variations affect female hormone profiles. We also discuss treatment options th at modulate levels of testosterone by targeting the expression of steroidogenic genes. Common variants in genes encoding DHEA sulphotransferase, aromatase, steroid 5a-reductase, androgen receptor, sex-hormone binding globulin, fragile X mental retardation protein and breast cancer type 1 susceptibility protein have been implicated in androgen metabolism and, therefore, can affect levels of androgens in women. Short of screening for all potential genetic variants, hormonal assessments of patients with low testosterone levels after DHEA supplementation facilitate identification of underlying genetic defects. The genetic predisposition of patients can then be used to design individualized fertility treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.